ArticleFrontiers in oncology2026
SinglePass electrocautery device for closure of lung and mediastinal biopsy: a case series of 5 patients.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Percutaneous computed tomography (CT)-guided biopsy, including coaxial core needle biopsy (CCNB), has become the primary and preferred method for obtaining tissue samples in diagnosing or characterizing thoracic lesions, often in the lung or mediastinum. Despite advances in imaging and various approaches in reducing bleeding in the biopsy tract, pneumothorax and perilesional or lesional hemorrhage remain at the forefront of potentially serious complications. The increased risk that comes with requirements for additional tissue samples, both in size and in number, in the management of lung cancer is also a concern. Subsequent interventions may be required if significant pneumothorax or high-grade hemorrhage occurs and while death is a possible outcome with these procedures, it is rare. Case presentation: This report of a series of five image-guided CCNB cases focused on lung and mediastinal mass lesions in which hemostasis and biopsy tract closure were obtained with the SinglePass Kronos electrocautery device. All biopsy procedures were successful, and no complications were reported through 30 days post-procedure. Imaging confirmed the absence of post-procedure pneumothorax and bleeding complications in all five cases. Conclusion: The SinglePass electrocautery device is a potentially valuable tool in minimizing pneumothorax and hemorrhagic complications in percutaneous lung and mediastinal mass CCNB procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.